Terms: = Kidney tumors AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Prognosis
6 results:
1. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
[TBL] [Abstract] [Full Text] [Related]
2. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating smad4/SMAD7 signals.
Zhai W; Li S; Zhang J; Chen Y; Ma J; Kong W; Gong D; Zheng J; Xue W; Xu Y
Mol Cancer; 2018 Nov; 17(1):157. PubMed ID: 30419914
[TBL] [Abstract] [Full Text] [Related]
3. TRPP2 Enhances Metastasis by Regulating Epithelial-Mesenchymal Transition in Laryngeal Squamous Cell Carcinoma.
Wu K; Shen B; Jiang F; Xia L; Fan T; Qin M; Yang L; Guo J; Li Y; Zhu M; Du J; Liu Y
Cell Physiol Biochem; 2016; 39(6):2203-2215. PubMed ID: 27832627
[TBL] [Abstract] [Full Text] [Related]
4. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/smad4 expression.
Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T
Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660
[TBL] [Abstract] [Full Text] [Related]
5. Nuclear expression of Smad proteins and its prognostic significance in clear cell renal cell carcinoma.
Park JH; Lee C; Suh JH; Chae JY; Moon KC
Hum Pathol; 2013 Oct; 44(10):2047-54. PubMed ID: 23668999
[TBL] [Abstract] [Full Text] [Related]
6. Renal parenchyma-sparing surgery as conservative treatment of renal cell carcinoma.
Ciancio G; Politano VA; Ferrell S; Block NL
Br J Urol; 1994 Oct; 74(4):422-30. PubMed ID: 7820417
[TBL] [Abstract] [Full Text] [Related]
